IDEAS home Printed from https://ideas.repec.org/a/nat/nature/v469y2011i7331d10.1038_nature09657.html
   My bibliography  Save this article

The challenge of new drug discovery for tuberculosis

Author

Listed:
  • Anil Koul

    (Janssen Research and Development, Johnson & Johnson, Turnhoutseweg 30, B-2340 Beerse, Belgium)

  • Eric Arnoult

    (Janssen Research and Development, Johnson & Johnson, Val de Reuil 27106, Cedex, France)

  • Nacer Lounis

    (Janssen Research and Development, Johnson & Johnson, Turnhoutseweg 30, B-2340 Beerse, Belgium)

  • Jerome Guillemont

    (Janssen Research and Development, Johnson & Johnson, Val de Reuil 27106, Cedex, France)

  • Koen Andries

    (Janssen Research and Development, Johnson & Johnson, Turnhoutseweg 30, B-2340 Beerse, Belgium)

Abstract

Sustaining the fight against TB Although vaccination has been successful in some countries, tuberculosis (TB) is more prevalent in the world today than ever before, with nearly 10 million new cases expected yearly. Anil Koul and colleagues report on the various new TB drugs and treatment regimens under development. The prospects for some of them are good, they conclude, but the TB pathogen Mycobacterium tuberculosis deploys a range of mechanisms to evade host-control measures, so it will be important to keep the drugs pipeline well supplied. In addition, successful control of TB will depend on economic and societal measures to bolster health-care infrastructure in developing countries where TB is particularly prevalent.

Suggested Citation

  • Anil Koul & Eric Arnoult & Nacer Lounis & Jerome Guillemont & Koen Andries, 2011. "The challenge of new drug discovery for tuberculosis," Nature, Nature, vol. 469(7331), pages 483-490, January.
    • Handle: RePEc:nat:nature:v:469:y:2011:i:7331:d:10.1038_nature09657
    DOI: 10.1038/nature09657
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/nature09657
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1038/nature09657?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Mariam O Fofana & Gwenan M Knight & Gabriela B Gomez & Richard G White & David W Dowdy, 2014. "Population-Level Impact of Shorter-Course Regimens for Tuberculosis: A Model-Based Analysis," PLOS ONE, Public Library of Science, vol. 9(5), pages 1-7, May.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:469:y:2011:i:7331:d:10.1038_nature09657. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.